U.S. flag

An official website of the United States government

NM_173491.4(LSM11):c.631G>A (p.Gly211Ser) AND Aicardi-Goutieres syndrome 8

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 16, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001568350.1

Allele description [Variation Report for NM_173491.4(LSM11):c.631G>A (p.Gly211Ser)]

NM_173491.4(LSM11):c.631G>A (p.Gly211Ser)

Gene:
LSM11:LSM11, U7 small nuclear RNA associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q33.3
Genomic location:
Preferred name:
NM_173491.4(LSM11):c.631G>A (p.Gly211Ser)
HGVS:
  • NC_000005.10:g.157754046G>A
  • NM_173491.4:c.631G>AMANE SELECT
  • NP_775762.1:p.Gly211Ser
  • NC_000005.9:g.157181054G>A
  • NM_173491.3:c.631G>A
Protein change:
G211S; GLY211SER
Links:
OMIM: 617910.0001; dbSNP: rs2113077087
NCBI 1000 Genomes Browser:
rs2113077087
Molecular consequence:
  • NM_173491.4:c.631G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Aicardi-Goutieres syndrome 8
Identifiers:
MONDO: MONDO:0030361; MedGen: C5551352; OMIM: 619486

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001792206OMIM
no assertion criteria provided
Pathogenic
(Aug 16, 2021)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing.

Uggenti C, Lepelley A, Depp M, Badrock AP, Rodero MP, El-Daher MT, Rice GI, Dhir S, Wheeler AP, Dhir A, Albawardi W, Frémond ML, Seabra L, Doig J, Blair N, Martin-Niclos MJ, Della Mina E, Rubio-Roldán A, García-Pérez JL, Sproul D, Rehwinkel J, Hertzog J, et al.

Nat Genet. 2020 Dec;52(12):1364-1372. doi: 10.1038/s41588-020-00737-3. Epub 2020 Nov 23.

PubMed [citation]
PMID:
33230297

Details of each submission

From OMIM, SCV001792206.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 2 Pakistani brothers (family AGS114) who died at age 2 years with Aicardi-Goutieres syndrome (AGS8; 619486), Uggenti et al. (2020) identified homozygosity for a c.631G-A transition (c.631G-A, NM_173491.3) in the LSM11 gene, resulting in a gly211-to-ser (G211S) substitution at a highly conserved residue. Their unaffected first-cousin parents were heterozygous for the mutation, which was not found in public variant databases. RT-qPCR in patient fibroblasts revealed enrichment for aberrantly polyadenylated forms of replication-dependent histone (RDH) mRNAs derived from different histone clusters. Similar changes were observed after siRNA knockdown of LSM11 in HEK293T, HCT116, and U2OS cells. Histone expression analysis showed reduced levels of HIST1H1E (142220), encoding the linker histone H1.4, in patient-derived fibroblasts compared to controls. Genomewide transcript expression analysis revealed a global increase in polyadenylated RDH mRNA transcripts in patient cells, with a concomitant reduction in mature nonpolyadenylated RDH gene transcripts. The authors concluded that G211S is a loss-of-function variant that disturbs RDH pre-mRNA processing. An ex vivo assay of interferon signaling status in patient blood showed upregulation of interferon-stimulated genes (ISGs), and there was increased expression of ISGs in patient fibroblasts. Histone subtype-specific antibodies revealed a marked reduction in the ratio of linker H1.4 to H1.2 in patient cells compared to controls, whereas the levels of core histones showed no difference. Wide-field microscopy and immunofluorescence demonstrated an altered nuclear distribution of CGAS (613973) in patient fibroblasts compared to controls, and patient cells also exhibited an increased frequency of misshapen nuclei, including nuclear membrane herniations with intense foci of CGAS.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023